Here are the top health stories for the day:
NMC considers new policy for FMGs, plans practical exam to waive remaining internship
The Apex Medical Education Regulatory body in India, the National Medical Commission (NMC) is considering to introduce a policy under which Foreign Medical Graduates (FMGs) may get a waiver from extended internships by undergoing a six-month medical practical skill examination, Education Times has reported.
As per the daily, the NMC is working on finalising the policy to test the clinical skills of the FMGs through a practical examination. Therefore, once the medical graduate from abroad clears this test, the Commission will waive off the remaining internship tenure of their Compulsory Rotatory Medical Internship (CRMI), officials sources informed ET.
For more information, click on the link below:
NTA will face consequences if NEET irregularities proven: Union Education Minister Pradhan
A few days after rejecting any paper leak claims in NEET 2024 this year, the Union Education Minister Dharmendra Pradhan has assured action against National Testing Agency (NTA) officials if they are found guilty of the ''irregularities'' in the conduct of 2024 MBBS entrance test.
Speaking to ANI on the matter, the Minister said, "On the recommendations of the Supreme Court, the order has been given for re-test of 1,563 candidates. Some irregularities have come to light in two places. I assure students and parents that the government has taken this seriously."
For more information, click on the link below:
Study reveals anti-malaria drug could treat Polycystic Ovary Syndrome
In a study published in the journal Science, the malaria drug artemisinin has shown promise in treating Polycystic Ovary Syndrome (PCOS) symptoms. PCOS disrupts hormone production, causing irregular periods, infertility, and other symptoms. It is often associated with insulin resistance, which can lead to weight gain and worsen the condition.
The study involved a clinical trial with 19 women suffering from PCOS. Researchers found that artemisinin improved menstrual cycle regularity and significantly lowered testosterone levels, a common hormonal imbalance in PCOS. Additionally, most participants saw a decrease in anti-Mullerian hormone levels, another marker for PCOS, and 12 women experienced restored menstrual regularity after three months of treatment.
Reference: Yang Liu et al.,; Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction; Science384,eadk5382(2024).DOI:10.1126/science.adk5382
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd